Immuron (IMRN) Raw Materials (2017 - 2020)

Immuron (IMRN) recorded quarterly Raw Materials of $1.7 million in Q4 2020, up 989.11% quarter-over-quarter from $158142.1 in Q2 2019.

Immuron (IMRN) Raw Materials (2017 - 2020) Analysis & Trends

Immuron's Raw Materials history runs 4 years deep, the most recent figure standing at $1.7 million for Q4 2020.

  • In Q4 2020, Raw Materials changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2020 stood at $1.7 million (changed N/A YoY), while the FY2020 annual figure was $1.7 million, changed N/A from the prior year.
  • Raw Materials was $1.7 million for Q4 2020 at Immuron, up from $158142.1 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.7 million in Q4 2020 to a low of $102421.5 in Q2 2017.
  • Historically, Raw Materials has averaged $533312.2 across 4 years, with a median of $154239.1 in 2019.
  • The sharpest annual moves came in 2018 and 2019: Raw Materials surged 46.78% in 2018, then advanced 5.19% in 2019.
  • A 4-year view of Raw Materials shows it stood at $102421.5 in 2017, then soared by 46.78% to $150336.2 in 2018, then grew by 5.19% to $158142.1 in 2019, then jumped by 989.11% to $1.7 million in 2020.
  • The last three Raw Materials figures came in at $1.7 million (Q4 2020), $158142.1 (Q2 2019), and $150336.2 (Q2 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immuron 921.61 Mn 921.58 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 1.72 Mn
Jun 30, 2019 158,142.12
Jun 30, 2018 150,336.18
Jun 30, 2017 102,421.52